prednisone has been researched along with Meningitis, Cryptococcal in 16 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Meningitis, Cryptococcal: Meningeal inflammation produced by CRYPTOCOCCUS NEOFORMANS, an encapsulated yeast that tends to infect individuals with ACQUIRED IMMUNODEFICIENCY SYNDROME and other immunocompromised states. The organism enters the body through the respiratory tract, but symptomatic infections are usually limited to the lungs and nervous system. The organism may also produce parenchymal brain lesions (torulomas). Clinically, the course is subacute and may feature HEADACHE; NAUSEA; PHOTOPHOBIA; focal neurologic deficits; SEIZURES; cranial neuropathies; and HYDROCEPHALUS. (From Adams et al., Principles of Neurology, 6th ed, pp721-2)
Excerpt | Relevance | Reference |
---|---|---|
"Serious renal pathological changes, mass proteinuria, higher SLEDAI, higher prednisone dose, and a decline in CD4+ T cells could be risk factors for CM in patients with LN." | 3.96 | Cryptococcal meningitis in patients with lupus nephritis. ( Chen, J; Chen, P, 2020) |
"The authors present the first case report of a patient with lymphoma who developed disseminated cryptococcal osteomyelitis and meningitis while being treated with the PEP-C (prednisone, etoposide, procarbazine and cyclophosphamide) chemotherapy regimen." | 3.78 | Cryptococcal osteomyelitis and meningitis in a patient with non-hodgkin's lymphoma treated with PEP-C. ( Brown, JM; Fan, AC; Felsher, DW; Fischbein, NJ; Howard, W; Hsieh, RW; McClellan, JS; To, CA, 2012) |
"Cryptococcal meningitis is an important fungal infection among systemic lupus erythematosus patients." | 2.53 | Cryptococcal meningitis in systemic lupus erythematosus patients: pooled analysis and systematic review. ( Boekhout, T; Chen, M; Deng, D; Fang, W; Guo, Y; Hagen, F; Liao, W; Liu, J; Ms, A; Pan, W; Xu, J; Zhang, P, 2016) |
"Sarcoidosis is an independent risk factor for cryptococcal infection; most patients with sarcoidosis who develop cryptococcal infection are not on immunosuppressive drugs." | 2.41 | Cryptococcal meningitis and sarcoidosis. ( Katz, JD; Ross, JJ, 2002) |
"He had multiple prior episodes of cryptococcal meningitis with complications necessitating ventriculoperitoneal shunt placement and was on suppressive fluconazole when he developed worsening brain manifestations." | 1.56 | Case Report: A Case of Severe Cryptococcal Immune Reconstitution Inflammatory Syndrome Presenting with Brain and Intradural Abscesses in an HIV Patient. ( Jeng, A; Kalinoski, T; Malenfant, J; Yim, C, 2020) |
"Invasive fungal infections are a major complication and an important cause of morbidity and mortality among solid organ transplant recipients." | 1.39 | Invasive fungal infections in renal transplant recipients: about 11 cases. ( Ayadi, A; Charffedine, K; Cheikhrouhou, F; Guidara, R; Hachicha, J; Makni, F; Néji, S; Sellami, H; Trabelsi, H; Yaich, S, 2013) |
"To identify the risk factors for cryptococcal meningitis in patients with HIV disease we conducted a nested case-control study of 37 incident cases of cryptococcal meningitis and 74 controls, identified from a cohort of more than 2000 HIV-infected patients." | 1.30 | Risk factors for cryptococcal meningitis in HIV-infected patients. ( Chaisson, RE; Moore, RD; Oursler, KA, 1999) |
"Two cases of cryptococcal meningitis occurring in patients with systemic lupus erythematosus (SLE) are presented, and 24 additional cases from the literature are reviewed." | 1.28 | Cryptococcal meningitis in systemic lupus erythematosus. ( Lally, EV; Spiegel, M; Zimmermann, B, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (18.75) | 18.2507 |
2000's | 3 (18.75) | 29.6817 |
2010's | 8 (50.00) | 24.3611 |
2020's | 2 (12.50) | 2.80 |
Authors | Studies |
---|---|
Chen, J | 1 |
Chen, P | 1 |
Kalinoski, T | 1 |
Malenfant, J | 1 |
Yim, C | 1 |
Jeng, A | 1 |
Mehta, GU | 1 |
Panackal, AA | 1 |
Murayi, R | 1 |
Bennett, JE | 1 |
Williamson, PR | 1 |
Chittiboina, P | 1 |
Su, B | 1 |
Zhang, Q | 1 |
Lv, J | 1 |
Trabelsi, H | 1 |
Néji, S | 1 |
Sellami, H | 1 |
Yaich, S | 1 |
Cheikhrouhou, F | 1 |
Guidara, R | 1 |
Charffedine, K | 1 |
Makni, F | 1 |
Hachicha, J | 1 |
Ayadi, A | 1 |
Gaube, G | 1 |
De Castro, N | 1 |
Gueguen, A | 1 |
Lascoux, C | 1 |
Zagdanski, AM | 1 |
Alanio, A | 1 |
Molina, JM | 1 |
Fang, W | 1 |
Chen, M | 1 |
Liu, J | 1 |
Hagen, F | 1 |
Ms, A | 1 |
Zhang, P | 1 |
Guo, Y | 1 |
Boekhout, T | 1 |
Deng, D | 1 |
Xu, J | 1 |
Pan, W | 1 |
Liao, W | 1 |
Morera, N | 1 |
Juan-Sallés, C | 1 |
Torres, JM | 1 |
Andreu, M | 1 |
Sánchez, M | 1 |
Zamora, MÁ | 1 |
Colom, MF | 1 |
Rosario, M | 1 |
Song, SX | 1 |
McCullough, LD | 1 |
To, CA | 1 |
Hsieh, RW | 1 |
McClellan, JS | 1 |
Howard, W | 1 |
Fischbein, NJ | 1 |
Brown, JM | 1 |
Felsher, DW | 1 |
Fan, AC | 1 |
Ross, JJ | 1 |
Katz, JD | 1 |
Lane, M | 1 |
McBride, J | 1 |
Archer, J | 1 |
Riera-Mestre, A | 1 |
de la Haba-Vacas, I | 1 |
Vidaller-Palacín, A | 1 |
Fernández-Viladrich, P | 1 |
Oursler, KA | 1 |
Moore, RD | 1 |
Chaisson, RE | 1 |
Zimmermann, B | 1 |
Spiegel, M | 1 |
Lally, EV | 1 |
Rajkumar, K | 1 |
Rajkumar, T | 1 |
Sagar, TG | 1 |
Maitreyan, V | 1 |
Shanta, V | 1 |
2 reviews available for prednisone and Meningitis, Cryptococcal
Article | Year |
---|---|
Cryptococcal meningitis in systemic lupus erythematosus patients: pooled analysis and systematic review.
Topics: Age Factors; China; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; M | 2016 |
Cryptococcal meningitis and sarcoidosis.
Topics: Adult; Brain; Cryptococcus neoformans; Female; Fluconazole; Humans; Meningitis, Cryptococcal; Predni | 2002 |
14 other studies available for prednisone and Meningitis, Cryptococcal
Article | Year |
---|---|
Cryptococcal meningitis in patients with lupus nephritis.
Topics: Adult; Case-Control Studies; CD4 Lymphocyte Count; Female; Fever; Glucocorticoids; Headache; Humans; | 2020 |
Case Report: A Case of Severe Cryptococcal Immune Reconstitution Inflammatory Syndrome Presenting with Brain and Intradural Abscesses in an HIV Patient.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Anti-Inflammatory Agents; Anti-Retroviral Agents | 2020 |
Corticosteroids for shunted previously healthy patients with non-HIV cryptococcal meningoencephalitis.
Topics: Adult; Aged; Dexamethasone; Female; Glucocorticoids; Humans; Intracranial Hypertension; Male; Mening | 2018 |
Cryptococcal meningitis in adult patients with primary nephrotic syndrome
.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Case-Control Studies; Creatin | 2018 |
Invasive fungal infections in renal transplant recipients: about 11 cases.
Topics: Adult; Anti-Bacterial Agents; Coinfection; Female; Graft Rejection; Humans; Immunocompromised Host; | 2013 |
Treatment with adalimumab for severe immune reconstitution inflammatory syndrome in an HIV-infected patient presenting with cryptococcal meningitis.
Topics: Adalimumab; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Anti-Inflammator | 2016 |
Cryptococcus gattii infection in a Spanish pet ferret (Mustela putorius furo) and asymptomatic carriage in ferrets and humans from its environment.
Topics: Amplified Fragment Length Polymorphism Analysis; Animals; Anti-Inflammatory Agents; Antifungal Agent | 2011 |
An unusual case of stroke.
Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diuretics; Female; Furo | 2012 |
Cryptococcal osteomyelitis and meningitis in a patient with non-hodgkin's lymphoma treated with PEP-C.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cryptococcus neoformans; Cy | 2012 |
Steroid responsive late deterioration in Cryptococcus neoformans variety gattii meningitis.
Topics: Acetazolamide; Adult; Amphotericin B; Antifungal Agents; Arachnoiditis; Cerebral Infarction; Dexamet | 2004 |
[Cryptococcal disease and immunosuppressive treatment].
Topics: Aged, 80 and over; Disease Susceptibility; Female; HIV Seronegativity; Humans; Immunocompromised Hos | 2006 |
Risk factors for cryptococcal meningitis in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Case-Control Studies; Cerebrospinal | 1999 |
Cryptococcal meningitis in systemic lupus erythematosus.
Topics: Adult; Amphotericin B; Cryptococcus; Female; Flucytosine; Humans; Lupus Erythematosus, Systemic; Men | 1992 |
Cryptococcal meningitis in a patient with Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Susceptibility; Hod | 1991 |